Arlington Financial Advisors, LLC Amgen Inc Transaction History

Arlington Financial Advisors, LLC

$427 Million
Q4 2024

A detailed history of Arlington Financial Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Arlington Financial Advisors, LLC holds 23,831 shares of AMGN stock, worth $6.74 Million. This represents 1.45% of its overall portfolio holdings.

Number of Shares

23,831

Previous 24,776 3.81%

Holding current value

$6.74 Million

Previous $7.98 Million 22.2%

% of portfolio

1.45%

Previous 2.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 28, 2025	SELL	$258.78 - $328.31 $244,547 - $310,252	-945 Reduced 3.81%	23,831 $6.21 Million
Q3 2024 Oct 31, 2024	SELL	$309.38 - $337.38 $52,903 - $57,691	-171 Reduced 0.69%	24,776 $7.98 Million
Q2 2024 Jul 16, 2024	SELL	$262.75 - $319.31 $196,274 - $238,524	-747 Reduced 2.91%	24,947 $7.79 Million
Q1 2024 Apr 17, 2024	BUY	$268.87 - $324.56 $70,175 - $84,710	261 Added 1.03%	25,694 $7.31 Million
Q4 2023 Jan 08, 2024	SELL	$255.7 - $288.46 $4,346 - $4,903	-17 Reduced 0.07%	25,433 $7.33 Million
Q3 2023 Nov 02, 2023	SELL	$218.65 - $271.46 $35,202 - $43,705	-161 Reduced 0.63%	25,450 $6.84 Million
Q2 2023 Jul 24, 2023	BUY	$214.27 - $253.37 $44,996 - $53,207	210 Added 0.83%	25,611 $5.69 Million
Q1 2023 May 05, 2023	SELL	$225.79 - $275.2 $196,211 - $239,148	-869 Reduced 3.31%	25,401 $6.14 Million
Q4 2022 Jan 18, 2023	BUY	$229.03 - $291.01 $26,796 - $34,048	117 Added 0.45%	26,270 $0
Q3 2022 Oct 18, 2022	SELL	$224.46 - $253.15 $288,880 - $325,804	-1,287 Reduced 4.69%	26,153 $5.9 Million
Q2 2022 Jul 13, 2022	BUY	$230.71 - $256.74 $73,135 - $81,386	317 Added 1.17%	27,440 $6.68 Million
Q1 2022 Apr 26, 2022	BUY	$219.27 - $242.57 $2.78 Million - $3.08 Million	12,680 Added 87.79%	27,123 $6.56 Million
Q4 2021 Jan 18, 2022	SELL	$198.88 - $227.6 $2.27 Million - $2.59 Million	-11,394 Reduced 44.1%	14,443 $3.25 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $23,986 - $28,103	113 Added 0.44%	25,837 $5.49 Million
Q2 2021 Jul 30, 2021	BUY	$233.58 - $259.14 $458,283 - $508,432	1,962 Added 8.26%	25,724 $6.27 Million
Q1 2021 Apr 23, 2021	BUY	$221.91 - $258.6 $165,544 - $192,915	746 Added 3.24%	23,762 $5.91 Million
Q4 2020 Jan 29, 2021	BUY	$216.38 - $257.67 $112,733 - $134,246	521 Added 2.32%	23,016 $5.29 Million
Q3 2020 Nov 03, 2020	BUY	$234.65 - $260.95 $2.08 Million - $2.32 Million	8,884 Added 65.27%	22,495 $5.72 Million
Q1 2020 Apr 09, 2020	SELL	$182.24 - $241.7 $58,316 - $77,344	-320 Reduced 2.3%	13,611 $2.76 Million
Q4 2019 Jan 15, 2020	SELL	$189.21 - $243.2 $174,073 - $223,744	-920 Reduced 6.19%	13,931 $3.36 Million
Q3 2019 Nov 08, 2019	SELL	$174.11 - $208.62 $25,245 - $30,249	-145 Reduced 0.97%	14,851 $2.87 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $54,104 - $60,995	292 Added 1.99%	14,996 $2.9 Million
Q2 2018 Aug 13, 2018	BUY	$166.05 - $186.51 $2.44 Million - $2.74 Million	14,704 New	14,704 $2.89 Million

Others Institutions Holding AMGN

# of Institutions

3,078

Shares Held

404M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $151B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arlington Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arlington Financial Advisors, LLC with notifications on news.

Account

Arlington Financial Advisors, LLC Amgen Inc Transaction History